Colorectal Cancer Patients Benefit from Biomarker-Guided Treatments in TAPUR Study

Jan 24, 2020

|

NEW YORK – The American Society of Clinical Oncology's basket trial has reported positive results from three treatment arms involving patients with biomarker-defined advanced colorectal cancer.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Menu

Colorectal Cancer Patients Benefit from Biomarker-Guided Treatments in TAPUR Study

To read the full story....

Breaking News

iOnctura Doses First Patient in Phase I Study of Novel PI3K Inhibitor for Solid Tumors

Oncologie, Moffitt to Collaborate on Developing Targeted Treatment for Gastric and GI Cancers

GSK's sNDA for Ovarian Cancer Drug Zejula Accepted by FDA

Takeda's Alunbrig sNDA for ALK-Positive Non-Small Cell Lung Cancer Accepted by FDA

Genetic Testing Challenges in Oncology: Confusion Over Colon Cancer Syndromes Leads to Wrong Testing

Profiling of Osteosarcomas Uncovers Numerous Mechanisms Blocking Immune Checkpoint Inhibitor Therapy Response

Featured White Papers

What's Popular?

Epic EMR Users Begin Integrating Genomics Data for Clinical Decision Support

Genetic Testing Challenges in Oncology: Confusion Over Colon Cancer Syndromes Leads to Wrong Testing

iOnctura Doses First Patient in Phase I Study of Novel PI3K Inhibitor for Solid Tumors

Follow-up Study Confirms Viability of PD-L1 as Biomarker for Pembrolizumab

Genentech Basket Trial Data Supports Genomic Profiling of Salivary Cancer Patients for Precision Treatment

Sponsorships